Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Opioid Receptors: Overview
Drug Therapy
Antianxiety Medications
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Capturing incarceration in the medical record: we cannot manage what we cannot measure.
Partially randomized preference trials in carceral health research: a methodology to advance equity and inclusion.
Criminalizing Serious Mental Illness: What Linked Urban Data Reveal and the Case for Community Care.
Traumatic brain injury among patients presenting from prison: a cohort study.
Rapid Buprenorphine Initiations for Cardiac Emergencies in Patients on High-dose Methadone: A Case Report.
Impact of Health Insurance Coverage on Diabetes Care Quality: A Systematic Review and Meta-analysis of Racial, Ethnic, and Gender Disparities in U.S. Adults with Type 2 Diabetes.
Assessment of Physician Advocacy Engagement: A Scoping Review and Proposal of an Assessment Tool.
Relative Burden of Social Determinants of Health on Diverse Populations of Health Resources and Services Administration Health Centers.
Addressing Moral Distress Among Gender-Affirming Healthcare Professionals.
Trainee-Led Patient Education to Increase Advance Care Planning in a Geriatric Primary Care Clinic.
Scholarly Outcomes of a Small Projects Grant Program.
Related Experiment Video
Updated: Sep 20, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Initiating Medications for Opioid Use Disorder in Hospitalized Incarcerated Patients.
Lawrence A Haber1,2, Justin Berk3, Julie Taub4,5
1Division of Hospital Medicine, Denver Health and Hospital Authority, Denver, CO, USA. lawrence.haber@dhha.org.
Medications for opioid use disorder (MOUD) are underutilized in incarcerated populations, despite reducing overdose deaths. Hospital-based clinicians can overcome barriers to equitable MOUD treatment for Black men.
Area of Science:
- Public Health
- Addiction Medicine
- Health Disparities
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Background:
- Opioid use disorder (OUD) disproportionately affects Black men, who also face higher incarceration rates.
- Medications for opioid use disorder (MOUD), including buprenorphine and methadone, are proven to reduce mortality but are underutilized in incarcerated individuals.
- Post-release overdose is a leading cause of death for recently incarcerated people, highlighting the need for timely treatment.